निर्यात तैयार है — 

MEK inhibitors against MET-amplified non-small cell lung cancer

Several receptor tyrosine kinases (RTKs) including EGFR, ALK, and MET have been identified as therapeutic targets in non-small cell lung cancer (NSCLC). Among the downstream pathways of RTKs, the MAPK pathway is particularly important for cancer cell proliferation, differentiation, and survival. In...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Int J Oncol
मुख्य लेखकों: Chiba, Masato, Togashi, Yosuke, Tomida, Shuta, Mizuuchi, Hiroshi, Nakamura, Yu, Banno, Eri, Hayashi, Hidetoshi, Terashima, Masato, De Velasco, Marco A., Sakai, Kazuko, Fujita, Yoshihiko, Mitsudomi, Tetsuya, Nishio, Kazuto
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: D.A. Spandidos 2016
विषय:
Articles
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5118002/
https://ncbi.nlm.nih.gov/pubmed/27748834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2016.3736
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन